Camille L. Bedrosian, EVP and Chief Medical Officer: Ultragenyx Pharmaceutical RARE Sell · Filed 23/03/03

Trade details

Type: Insider sale
Amount: $175,615.25
Shares · price: 3,881 sh · $45.25 a share
Held after: 46,720 sh
Stock: Ultragenyx Pharmaceutical RARE
Person: Camille L. BedrosianEVP and Chief Medical Officer
Trade date: 23/03/01
Filed: 23/03/03
Days to filing: 2 days

Sold 7.7% of holdings

Share of holding sold: 7.7%

Ultragenyx Pharmaceutical trades, last 26 weeks

What else happened in Ultragenyx Pharmaceutical around then

Filed or reported within 30 days of the trade day · 23/01/30~23/03/31

Camille L. Bedrosian's recent trades

Camille L. BedrosianOfficer
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$324.9K
10,028 sh
$324.9K
Filed 09/11
Traded 09/10
Camille L. BedrosianDirector
Planned saleRhythm Pharmaceuticals
Planned sale
Rhythm Pharmaceuticals
RYTM
$5.8M
64,540 sh
$5.8M
Filed 03/04
Traded 03/04
Camille L. BedrosianChief Medical Officer
SellAmylyx Pharmaceuticals
Sell
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/04
Traded 03/02
Camille L. BedrosianDirector
Planned saleRhythm Pharmaceuticals
Planned sale
Rhythm Pharmaceuticals
RYTM
$3.2M
35,460 sh
$3.2M
Filed 03/03
Traded 03/03
Camille L. BedrosianOfficer
Planned saleAmylyx Pharmaceuticals
Planned sale
Amylyx Pharmaceuticals
AMLX
$94.2K
6,461 sh
$94.2K
Filed 03/02
Traded 03/02

Camille L. Bedrosian, Chief Officer — sold $175.6K of Ultragenyx Pharmaceutical RARE · 7.7% of holdings | Whalegun